NASDAQ
CNXU
Last Price
US $7.97
Valuation
Financial
Performance
Cash flow to debt coverage
Conexeu Sciences Inc. balance-sheet data unavailable; cash-flow debt coverage cannot be computed.
Free cash flow growth
Conexeu Sciences Inc. has insufficient data to evaluate this check.
Debt-to-equity ratio
Conexeu Sciences Inc. has insufficient data to evaluate this check.
Debt-to-equity trend
Conexeu Sciences Inc. has insufficient data to evaluate this check.
Net debt to EBITDA
Conexeu Sciences Inc. has negative EBITDA, making leverage ratio unreliable
Interest coverage
Conexeu Sciences Inc. interest expense data unavailable for the most recent period; interest coverage ratio cannot be reliably computed.
Profit margin growth
Conexeu Sciences Inc. has insufficient data to evaluate this check.
Current ratio
Conexeu Sciences Inc. has insufficient data to evaluate this check.
Return on assets
Conexeu Sciences Inc.'s return on assets of 0.00% is lower than the 5.00% threshold, indicating inefficient asset utilization
Return on equity
Conexeu Sciences Inc.'s return on equity of 0.00%, is lower than 15.00%, indicating bad performance
Earnings quality
Conexeu Sciences Inc. has insufficient data to evaluate this check.
Earnings stability
Conexeu Sciences Inc. has insufficient public price history to evaluate earnings stability.
Positive free cash flow
Conexeu Sciences Inc. has negative free cash flow, indicating the company is burning cash rather than generating it
Free cash flow yield
Conexeu Sciences Inc. has a free cash flow yield of 0.00%, which is below the 2.00% threshold, indicating limited cash return relative to market value
Earnings growth
Conexeu Sciences Inc. has insufficient data to evaluate this check.
Revenue growth
Conexeu Sciences Inc. has insufficient data to evaluate this check.
Return on invested capital
ROIC is unavailable for Conexeu Sciences Inc.; this check cannot be evaluated.
3-year revenue CAGR
Conexeu Sciences Inc. has insufficient revenue history to calculate 3-year revenue CAGR.
Revenue consistency
Conexeu Sciences Inc. has insufficient public price history to evaluate revenue consistency.
Return on equity consistency
Conexeu Sciences Inc. has insufficient public price history to evaluate ROE consistency.
Cash Flow Valuation (DCF)
Conexeu Sciences Inc. has insufficient data to evaluate this check.
Earnings yield (TTM)
Conexeu Sciences Inc. has insufficient data to evaluate this check.
EBITDA Valuation
Conexeu Sciences Inc. is overvalued relative to its fair value price of 0.00 based on EBITDA multiple model
EV/EBITDA (FY)
Conexeu Sciences Inc. has negative or missing EBITDA, making EV/EBITDA ratio unreliable
PEG ratio (TTM/FY)
Conexeu Sciences Inc. has insufficient data to calculate the PEG ratio.
Price-to-book ratio (FY)
Conexeu Sciences Inc. has negative shareholder equity; price-to-book is not meaningful and the check fails
Price-to-sales ratio (TTM)
Conexeu Sciences Inc. has a price-to-sales ratio of 999.00x, which exceeds the 8.00x threshold, indicating the stock may be overvalued relative to its revenue
Profit margin
Current Ratio
Capital Returns
-
Return on equity
ROIC: -
Valuation History
-
Price to Earnings
EV/EBITDA: -
Cash flow
Profit margin
-
Fair Value
Market $7.97
—
Default assumptions
Base valuations use default assumptions. Customize in the Valuator.